Stem Cell Clinic

Cerus Corporation Announces a Five-Year Tender Award by the Hong Kong Red Cross Blood Transfusion Service for INTERCEPT Blood Systems – BioSpace

By adminJuly 31, 2020Stem Cell Medicine

CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (Nasdaq:CERS) today announced it has been awarded a five-year tender by the Hong Kong Red Cross Blood Transfusion Services (BTS) for INTERCEPT Blood System for platelets. The Hong Kong Red Cross BTS is the only public institution providing blood to all hospitals, public and private, in Hong Kong.

Following a thorough selection process, we are pleased to be selected by the Hong Kong Red Cross BTS to supply INTERCEPT Blood System for platelets, said Pascal Maillard, Cerus vice president of commercial operations for the Asia Pacific region. INTERCEPT for platelets provides a robust, broad-spectrum inactivation, reducing the risks of transfusion-transmitted infections and thereby enhancing patient care.

This is an important contract for Cerus, continued Maillard. The Hong Kong Red Cross BTS is a member of the influential Asia Pacific Blood Network (APBN) and a key opinion leader globally. This tender award presents a unique opportunity to expand the use of INTERCEPT in Asia-Pacific, a region that represents a significant market growth opportunity for Cerus.

The tender award builds upon the prior experience of the Hong Kong Red Cross BTS with the INTERCEPT Blood System for platelets. The Hong Kong Red Cross BTS, in collaboration with the Queen Mary Hospital, conducted a clinical study successfully transfusing INTERCEPT treated platelet components prepared without leukocyte reduction, without bacterial screening, and without gamma irradiation to allogeneic Hematopoietic Stem Cell Transplant (HSCT) patients (Sim, Tsoi et al. 2019).

This innovative study conducted by the Hong Kong Red Cross BTS and Queen Mary Hospital has the potential to change how patients are supported with platelet transfusions, said Dr. Laurence Corash, Cerus chief scientific officer. The study indicated that INTERCEPT treatment could potentially replace leukocyte filtration, a common practice to reduce the incidence of febrile transfusion reactions, alloimmunization, and cytomegalovirus (CMV) infection. The INTERCEPT platelet system has already demonstrated widespread replacement of bacterial screening, gamma irradiation, and CMV serology in the EU and U.S.

The Hong Kong Red Cross BTS recently completed renovations and is a state-of-the-art facility that manufactures approximately 40,000 platelet doses per year, a portion of which will be treated with INTERCEPT.

Sim, J., W. C. Tsoi, et al. (2019). "Transfusion of pathogen-reduced platelet components without leukoreduction." Transfusion 59(6): 1953-1961.

ABOUT CERUS

Cerus Corporation is dedicated solely to safeguarding the worlds blood supply and aims to become the preeminent global blood products company. Based in Concord, California, our employees are dedicated to deploying and supplying vital technologies and pathogen-protected blood components for blood centers, hospitals and ultimately patients who rely on safe blood. With the INTERCEPT Blood System, we are focused on protecting patients by delivering the full complement of reliable products and expertise for transfusion medicine. Cerus develops and markets the INTERCEPT Blood System and remains the only company in the blood transfusion space to earn both CE Mark and FDA approval for pathogen reduction of both platelet and plasma components. Cerus currently markets and sells the INTERCEPT Blood System in the United States, Europe, the Commonwealth of Independent States, the Middle East and selected countries in other regions around the world. The INTERCEPT Red Blood Cell system is in clinical development. For more information about Cerus, visit http://www.cerus.com and follow us on LinkedIn.

INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus Corporation.

Forward Looking Statements

Except for the historical statements contained herein, this press release contains forward-looking statements concerning Cerus belief that the INTERCEPT Blood System has the potential to change how patients are supported with platelet transfusions and to potentially replace leukocyte filtration, and other statements that are not historical facts. Actual results could differ materially from these forward-looking statements as a result of certain factors, including, without limitation: risks related to Cerus ability to demonstrate to the transfusion medicine community and other health care constituencies that pathogen reduction and the INTERCEPT Blood System is safe, effective and economical; the risk that applicable regulatory authorities and healthcare practitioners may disagree with Cerus interpretations of the data from its clinical studies; as well as other risks detailed in Cerus filings with the Securities and Exchange Commission, including Cerus Quarterly Report on Form 10-Q for the quarter ended March 31, 2020, filed with the SEC on May 5, 2020. In addition, to the extent that the COVID-19 pandemic adversely affects Cerus business and financial results, it may also have the effect of heightening many of the other risks and uncertainties described above. Cerus disclaims any obligation or undertaking to update or revise any forward-looking statements contained in this press release.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200730005316/en/

Stem Cells Market is expected to pick up in healthy CAGR by 2020-2025 Top companies | Chiesi Pharmaceuticals, JCR Pharmaceutical, Pharmicell,…

By adminJuly 31, 2020Embryonic Stem Cells

Stem Cells Market Overview 2020 2025

This has brought along several changes in This report also covers the impact of COVID-19 on the global market.

The risingtechnology in Stem Cells Marketis also depicted in thisresearchreport. Factors that are boosting the growth of the market, and giving a positive push to thrive in the global market is explained in detail.

Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: Embryos formed during the blastocyst phase of embryological development (embryonic stem cells) and Adult tissue (adult stem cells). Both types are generally characterized by their potency, or potential to differentiate into different cell types (such as skin, muscle, bone, etc.). This report studies the Stem Cell Therapy. Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.

Get a Sample PDF copy of the report @ https://reportsinsights.com/sample/13815

Key Competitors of the Global Stem Cells Market are: , Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, JCR Pharmaceutical, Pharmicell, Medi-post, Anterogen, MolMed, Takeda (TiGenix)

Historical data available in the report elaborates on the development of the Stem Cells on national, regional and international levels. Stem Cells Market Research Report presents a detailed analysis based on the thorough research of the overall market, particularly on questions that border on the market size, growth scenario, potential opportunities, operation landscape, trend analysis, and competitive analysis.

Major Product Types covered are: Allogeneic Autologous

Major Applications of Stem Cells covered are: Musculoskeletal Disorder Wounds & Injuries Cornea Cardiovascular Diseases Others

This study report on global Stem Cells market throws light on the crucial trends and dynamics impacting the development of the market, including the restraints, drivers, and opportunities.

To get this report at a profitable rate.: https://reportsinsights.com/discount/13815

The fundamental purpose of Stem Cells Market report is to provide a correct and strategic analysis of the Stem Cells industry. The report scrutinizes each segment and sub-segments presents before you a 360-degree view of the said market.

Market Scenario:

The report further highlights the development trends in the global Stem Cells market. Factors that are driving the market growth and fueling its segments are also analyzed in the report. The report also highlights on its applications, types, deployments, components, developments of this market.

Highlights following key factors:

:-Business descriptionA detailed description of the companys operations and business divisions. :-Corporate strategyAnalysts summarization of the companys business strategy. :-SWOT AnalysisA detailed analysis of the companys strengths, weakness, opportunities and threats. :-Company historyProgression of key events associated with the company. :-Major products and servicesA list of major products, services and brands of the company. :-Key competitorsA list of key competitors to the company. :-Important locations and subsidiariesA list and contact details of key locations and subsidiaries of the company. :-Detailed financial ratios for the past five yearsThe latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Our report offers:

Market share assessments for the regional and country level segments. Market share analysis of the top industry players. Strategic recommendations for the new entrants. Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets. Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations). Strategic recommendations in key business segments based on the market estimations. Competitive landscaping mapping the key common trends. Company profiling with detailed strategies, financials, and recent developments. Supply chain trends mapping the latest technological advancements.

Access full Report Description, TOC, Table of Figure, Chart, etc. @ https://reportsinsights.com/industry-forecast/Stem-Cells-Market-13815

About US:

Reports Insights is the leading research industry that offers contextual and data-centric research services to its customers across the globe. The firm assists its clients to strategize business policies and accomplish sustainable growth in their respective market domain. The industry provides consulting services, syndicated research reports, and customized research reports.

:(US) +1-214-272-0234

:(APAC) +91-7972263819

Email:[emailprotected]

Sales:[emailprotected]

Read the rest here:
Stem Cells Market is expected to pick up in healthy CAGR by 2020-2025 Top companies | Chiesi Pharmaceuticals, JCR Pharmaceutical, Pharmicell,...

Rheumatoid Arthritis Stem Cell Therapy Market Shares, Strategies and Forecast Worldwide, 2018 to 2028 Bulletin Line – Bulletin Line

By adminJuly 31, 2020Stem Cell Treatment

Fact.MR, in its recently published market research report, provides an in-depth analysis of the Rheumatoid Arthritis Stem Cell Therapy market included the anticipated growth pattern of the market over the forecast period (2019-2029). A detailed assessment of the various micro and macro-economic factors that are likely to shape the course of the Rheumatoid Arthritis Stem Cell Therapy market over the next decade is enclosed in the report. The study suggests that the Rheumatoid Arthritis Stem Cell Therapy market is expected to register a CAGR growth of XX% over the forecast period primarily driven by factors including factor 1, factor 2, factor 3, and factor 4.

Further, the methodical and systematic approach adopted by the analysts while curating the report ensures that the data in the report is insightful, relevant, and a valuable tool for our clients to gain a competitive advantage in the current and future market landscape.

Request Sample Report @ https://www.factmr.co/connectus/sample?flag=S&rep_id=1001

Competitive assessment

The competitive assessment included in the report throws light on the business strategies incorporated by leading market players operating in the Rheumatoid Arthritis Stem Cell Therapy market. The comprehensive study provides a birds eye view of the business operations of top-tier market players along with relevant graphs, figures, and tables.

Regional analysis

The regional analysis section touches upon the market scenario in the various geographies worldwide and the factors that are projected to influence the market dynamics in each region. The impact of the economic and political policies of different countries in each region is discussed in the report in detail.

End Use study

The report bifurcates the Rheumatoid Arthritis Stem Cell Therapy market on the basis of end-use and tracks the Y-o-Y growth of each end use segment.

Competitive landscape

Request Methodology On This Report @ https://www.factmr.co/connectus/sample?flag=RM&rep_id=1001

Important questions answered in the report:

Why Choose Fact.MR?

Ask analyst about this report at https://www.factmr.co/connectus/sample?flag=AE&rep_id=1001

See original here:
Rheumatoid Arthritis Stem Cell Therapy Market Shares, Strategies and Forecast Worldwide, 2018 to 2028 Bulletin Line - Bulletin Line

Crowdfunding to the rescue for this cancer patient – Social News XYZ

By adminJuly 30, 2020Stem Cell Doctors

Home IANS Life Crowdfunding to the rescue for this cancer patient

Posted By: Gopi July 30, 2020

By Siddhi Jain

New Delhi, July 30 (SocialNews.XYZ) Cancer takes innumerable lives each year, and so does the unavailability of cancer treatment due to lack of funds. 33-year-old Nushafreen Palsetia, a software engineer based in Mumbai, was recently diagnosed with a very aggressive form of cancer. Despite a relapse, what helped was life-saving support pouring from over 1,700 donors.

Nushafreen was first diagnosed with Non-Hodgkin Lymphoma in April 2019. After a year of enduring aggressive treatment, she tried to get back to her normal life and work. Unfortunately, Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma (DLBCL), cancer relapsed in her liver in May 2020 which was an unexpected major shock, leaving her and all of her family overwhelmed.

Doctors planned to perform an autologous (her own stem cells) bone marrow transplant in India after the chemotherapy but further tests showed involvement of the bone marrow as well. Hence, her treating doctor recommended the modern CAR-T Cell therapy treatment, available only in the USA, UK, Israel, and a few European countries.

Nushafreen's family found Israel as the most affordable option as compared to all other countries offering the treatment. They reached out to Sheba Medical Centre in Israel which estimated the medical expenses as 200,000 USD (approximately Rs 1.5 crore). The treatment will require Nushafreen to be hospitalized for a month or more for the response to treatment and immediate follow up.

As Nushafreen's family couldn't afford the high medical expenses, an ImpactGuru crowdfunding campaign was initiated. In two weeks, Nushafreen's ImpactGuru.com Page has raised over Rs 1 crore from 1750 donors. The platform raises money online for medical expenses via crowdfunding such as cancer, transplants, and accidents.

According to the co-founder and CEO of the healthcare crowdfunding platform, Piyush Jain, "Crowdfunding is driven by a culture of generosity, it allows people to raise money quickly in a hassle free manner without any payback liability. This is a new record for our platform with a single patient's family being able to raise more than Rs 1 crore. We hope Nushafreen recovers soon and more patients come forward to utilize our platform in their time of need to get the best available treatment for critical illnesses."

(Siddhi Jain can be contacted at siddhi.j@ians.in)

Source: IANS

Gopi Adusumilli is a Programmer. He is the editor of SocialNews.XYZ and President of AGK Fire Inc.

He enjoys designing websites, developing mobile applications and publishing news articles on current events from various authenticated news sources.

When it comes to writing he likes to write about current world politics and Indian Movies. His future plans include developing SocialNews.XYZ into a News website that has no bias or judgment towards any.

He can be reached at gopi@socialnews.xyz

Like Loading...

Read the original here:
Crowdfunding to the rescue for this cancer patient - Social News XYZ

Scientists to speed creation of pig vaccines – FarmingUK

By adminJuly 30, 2020Stell Cell Research

Scientists want to combat African swine fever, a highly contagious, potentially fatal disease, and Porcine Reproductive and Respiratory Syndrome, found in commercial herds

Scientists are developing a method to speed the creation of vaccines for devastating pig diseases, such as African swine fever.

British researchers are aiming to establish a reliable, large-scale system to develop and test vaccines for viral infections.

Stem cell technology will be used to develop a source of white blood cells, identical to those affected by disease in pigs, which can be used to develop vaccines containing live virus.

The team, involving scientists from the Roslin Institute and the Animal and Plant Health Agency (APHA), are particularly investigating control strategies against African swine fever virus.

Results from the study are expected to shed light on how diseases such as ASF target white blood cells, and how the cells respond to infection.

The approach seeks to improve on current vaccine testing methods, which include using blood cells derived from other animal species, or from other types of cells that resemble blood cells.

Stem cells those in early stage of development, which can differentiate into blood cells hold promise as a source of blood cells as they are likely to be free of contamination with disease, leading to accurate, reliable results.

Genetic modification techniques may also enable researchers to develop more efficient production of blood cells.

This approach may also enable scientists to explore whether lab-produced blood cells are able to contain high levels of virus, making them effective for vaccine development.

In addition, the application of genome editing technology to blood and virus cells could aid understanding of the role of genes in infectivity, immune response, and resistance to disease.

Dr Tom Burdon, research group leader at Roslin Institute said: "Stem cell technology applied to vaccine development can not only speed the delivery of results but limit the need for research involving animals.

"We hope that our efforts will aid the search for effective vaccines against serious diseases, which affect millions of animals and incur great cost to farmers."

See the original post:
Scientists to speed creation of pig vaccines - FarmingUK

Arson at The Way Christian Center and The Shortage of Stem Cell Donors of Color – KPFA – 94.1FM

By adminJuly 30, 2020Stem Cell Treatment

Davey D brings us audio from todays press conference held at The Way Christian Center in Berkeley Ca. Less than 12 hours after The Way Christian Center placed a Black Lives Matter banner, someone set fire to several trash cans positioned at the back of the church. The act of arson, damaged a portion of the building (see photos below) and has created fear and anger in the community.

Later we speak with Jess Tom and Carol Gillespie about treatment for blood-related cancers, the shortage of stem cell donors of color and the need to improve the registries. Seventy percent of patients wont have a match in their families and must find an unrelated donor. Patients are more likely to match donors who share the same ethnic background, but the lack of diversity on the Be The Match national registry makes it difficult for patients to find one. The Asian American Donor Program (AADP,

Guests:

Pastor Michael McBride (known as Pastor Mike) The fire was an act of terror, said Pastor Michael McBride, who leads the 48-year-old Way Christian Church.

Pastor Michael McBride is a native of San Francisco, CA. and has been active in ministry for almost 20 years. In June 2005, Pastor McBridelaunched a new ministry, The Way Christian Center in West Berkeley, where he presently serves as thePastor.

Carol Gillespie, Executive Director, Asian American Donor Program

Carol Gillespie is one of the original members of the Board of Directors for the Asian American Donor Program (AADP) when it was founded in 1989. She volunteered for AADP for3 years before accepting the position as Project Administrator in 1992. In 2002, Gillespie was selected as AADPs Executive Director and is currently serving in that position.

Jess Tom, Chef, Author, and TV Guest

Jess Tom is the sister of Andrew, who at 29 years old was living his dream and engaged to the love of his life. In May 2020 Andrew went to the doctor for swollen lymph nodes. A couple of days later, he was diagnosed withmixed phenotype acute leukemia (MPAL), a rare and aggressive form of leukemia. MPAL accounts for only 2-5% of all leukemias. The only way he can beat the illness is with a stem cell transplant.

In order to have a stem cell transplant, first a stem cell match for Andrew must be found. No one in Andrews family is a match. As being a match is genetically based, Andrews stem cell match will most likely be someone who is Chinese.Chinese donors only make up 0.7% of the national donor registry, leaving him with only a 43% chance of finding a perfect match.

Jess Tom has been working with the Asian American Donor Program, a nonprofit organization, to encourage Chinese Americans to register as potential stem cell donors. Sheis a chef and winner of season 14 ofFood Network Star. Jess Tom is a writer and food blogger living in Brooklyn.

She is the author ofFOOD WHORE: A Novel of Dining & Deceitpublished by William Morrow/HarperCollins. The paperback edition was released in 2015.FOOD WHORE, Jess first novel, merges her love of food and fiction.

You can find Jess on stage, online and on television, appearing on the Food Network, Good Morning America, the Today Show, and more.She has worked on initiatives with food trucks, restaurants, hospitality startups, and citywide culinary programs.

What Is the Impact of COVID-19 on Cancer Stem Cells Market During Projected Period of 2020-2026? – Owned

By adminJuly 30, 2020Stem Cell Treatment

According to a study, Cancer Stem Cells Market by Research Dive, the global market will surpass $1,722.7 million by 2026. Rising number of cancer patients, coupled with the latest advancements in cancer stem cells will upsurge the global market by the year 2026.

Rising tension of cancer all over the world is one of the significant factor which drives the growth of cancer stem cells market. According to the World Health Organization (WHO), one out of six deaths are occurs due to cancers such as breast cancer, lungs cancer and others. The causes for the growing cases of cancer patients include urban air pollution, sexually transmitted HPV infection, alcohol consumption, poor intake of fruit and vegetables. Moreover, late-stage presentation and inaccessible diagnosis are the common factor which increases risk of cancer. On the other hand, stem cell research has capability to manufacture different types of medicines for diseases along with finding drugs that can be used for treatment of cancer.

Connect with Analyst to Reveal How COVID-19 Impacting On Cancer Stem Cells Market:https://www.researchdive.com/connect-to-analyst/32

However, issues such as expensive stem cell therapy treatments & strict international rules and are hampering the global cancer stem cells market growth. Such therapy utilizes living cells to treat disease coupled with processes like collecting, altering, storing and applying to technology. Thus, the cost of stem cell therapy ranges between $5,000 to $8,000 per stem cell treatment also it can be around $25,000 or more than that. Researchers of Tel Aviv University introduced newly advanced biosensor which can target leukemic stem cells. They are more focusing on decreasing the rate of relapse in blood cancer by targeting most malignant leukemic stem cells. Such latest technological advancements anticipated to drive the growth of market. Stem cell research is the rapidly growing medical practice in Turkey. Therefore, this country is now recognized as rising star of Europe in stem cell. Turkish hospitality and friendliness is well deserved along with high quality, low cost stem cell treatment, modern laboratory equipment creating enormous opportunities for the investors of stem cells.

Breast cancer market will surpass $295.0 million in the year 2026, and is anticipated to rise at 10.4% CAGR during the estimate period. The cancer stem cells market for bladder is anticipated to increase at 11.2% CAGR, and will surpass $275.8 million by 2026, rising from $117.9 million in 2018.

Global market for stem cell based cancer therapy was $440.3 million by end of 2018 and is anticipated to grow at 9.3% CAGR. This is majorly due to the rising advancements in stem cell therapy of Asia-Pacific and Europe region.

Click Here to Download Sample Copy of the Report at:https://www.researchdive.com/download-sample/32

North America cancer stem cell market is generated revenue of $365.64 million by end of 2018 and is anticipated to rise at 10% CAGR during the analyzed period. Asia-Pacific market registered a growth rate of 11.2% during the forecast period. This market will surpass $367.68 million by 2026, growing from $157.26 million in 2018. China, India, and Japan are the key contributors to the growth of regional market.

Some of the major players in the global cancer stem cells market are AdnaGen GmbH, Advanced Cell Diagnostics, Inc., AVIVA Biosciences Corporation, Celula, Inc., Epic Sciences, Inc., Fluxion Biosciences, Inc., Rarecells USA, Inc. and Silicon Biosystems, S.p.A. These players are initiating various steps in order strengthen their presence such as merger & acquisitions, new product development etc. For instance, in January 2019, Fluxion Biosciences launched custom liquid biopsy NGS (Next Generation Sequencing) panel development. In liquid biopsy, NGS has been applied to sequencing of circulating tumor DNA. This technology has led to noteworthy reduction in the cost of sequencing coupled with improved accuracy.

Mr. Abhishek Paliwal Research Dive 30 Wall St. 8th Floor, New York NY 10005 (P) + 91 (788) 802-9103 (India) +1 (917) 444-1262 (US) Toll Free : +1 -888-961-4454 Email:[emailprotected] LinkedIn:https://www.linkedin.com/company/research-dive Twitter:https://twitter.com/ResearchDive Facebook:https://www.facebook.com/Research-Dive Blog:https://www.researchdive.com/blog Follow us on:https://covid-19-market-insights.blogspot.com

See the article here:
What Is the Impact of COVID-19 on Cancer Stem Cells Market During Projected Period of 2020-2026? - Owned

Cell Culture Market Research Report by Product, by End User, by Application – Global Forecast to 2025 – Cumulative Impact of COVID-19 – GlobeNewswire

By adminJuly 30, 2020Stell Cell Research

July 30, 2020 19:07 ET | Source: ReportLinker

New York, July 30, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Cell Culture Market Research Report by Product, by End User, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p05940079/?utm_source=GNW

The Global Cell Culture Market is expected to grow from USD 16,371.34 Million in 2019 to USD 33,826.78 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 12.85%.

Market Segmentation & Coverage: This research report categorizes the Cell Culture to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the Cell Culture Market studied across Consumables and Equipment. The Consumables further studied across Bioreactor Accessories, Sera, Media, and Reagents, and Vessels. The Equipment further studied across Bioreactors, Storage Equipment, and Supporting Equipment.

Based on End User , the Cell Culture Market studied across Cell Banks, Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, and Research Institutes.

Based on Application , the Cell Culture Market studied across Biopharmaceutical Production, Diagnostics, Drug Screening & Development, Stem Cell Research, and Tissue Engineering & Regenerative Medicine.

Based on Geography, the Cell Culture Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles: The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Cell Culture Market including CellGenix GmbH, Corning Incorporated, Danaher Corporation, Eppendorf AG, Fujifilm Irvine Scientific, GE Healthcare, Hi-Media Laboratories, Invivogen, Lonza Group AG, Merck KGaA, Miltenyi Biotec, Promocell, Sartorius AG, and Thermo Fisher Scientific Inc..

FPNV Positioning Matrix: The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cell Culture Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window: The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19: COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers: 1. Market Penetration: Provides comprehensive information on the market offered by the key players 2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as: 1. What is the market size and forecast of the Global Cell Culture Market? 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cell Culture Market during the forecast period? 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cell Culture Market? 4. What is the competitive strategic window for opportunities in the Global Cell Culture Market? 5. What are the technology trends and regulatory frameworks in the Global Cell Culture Market? 6. What are the modes and strategic moves considered suitable for entering the Global Cell Culture Market? Read the full report: https://www.reportlinker.com/p05940079/?utm_source=GNW

About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

More:
Cell Culture Market Research Report by Product, by End User, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19 - GlobeNewswire

Research report covers the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Forecasts and Growth, 2019-2025 – Market Research…

By adminJuly 30, 2020Stell Cell Research

This report presents the worldwide Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market size (value, production and consumption), splits the breakdown (data status 2018 and forecast to 2025), by manufacturers, region, type and application.

This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porters Five Forces Analysis.

The report presents the market competitive landscape and a corresponding detailed analysis of the major vendor/key players in the market.

Get PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2601860&source=atm

The report provides a valuable source of insightful data for business strategists and competitive analysis of Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market. It provides the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies industry overview with growth analysis and futuristic cost, revenue and many other aspects. The research analysts provide an elaborate description of the value chain and its distributor analysis. This Tire Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies study provides comprehensive data which enhances the understanding, scope and application of this report.

The key players covered in this study Orange County Hair Restoration Center Hair Sciences Center of Colorado Anderson Center for Hair Evolution Hair Loss Institute Savola Aesthetic Dermatology Center Virginia Surgical Center Hair Transplant Institute of Miami Colorado Surgical Center & Hair Institute

Market segment by Type, the product can be split into Platelet Rich Plasma Injections Stem Cell Therapy Market segment by Application, split into Dermatology Clinics Hospitals

Market segment by Regions/Countries, this report covers North America Europe China Japan Southeast Asia India Central & South America

The study objectives of this report are: To analyze global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies status, future forecast, growth opportunity, key market and key players. To present the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies are as follows: History Year: 2015-2019 Base Year: 2019 Estimated Year: 2020 Forecast Year 2020 to 2026 For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.marketresearchhub.com/enquiry.php?type=E&repid=2601860&source=atm

Regional Analysis For Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market:

For comprehensive understanding of market dynamics, the global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market is analyzed across key geographies namely: United States, China, Europe, Japan, South-east Asia, India and others. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.

Influence of the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market report:

-Comprehensive assessment of all opportunities and risk in the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market.

Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market recent innovations and major events.

-Detailed study of business strategies for growth of the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market-leading players.

-Conclusive study about the growth plot of Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market for forthcoming years.

-In-depth understanding of Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market-particular drivers, constraints and major micro markets.

-Favorable impression inside vital technological and market latest trends striking the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market.

The report has 150 tables and figures browse the report description and TOC:

Table of Contents of Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market

1 Study Coverage

1.1 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Product

1.2 Key Market Segments in This Study

1.3 Key Manufacturers Covered

1.4 Market by Type

1.4.1 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size Growth Rate by Type

1.4.2 Hydraulic Dredges

1.4.3 Hopper Dredges

1.4.4 Mechanical Dredges

1.5 Market by Application

1.5.1 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size Growth Rate by Application

You can Buy This Report from Here @ https://www.marketresearchhub.com/checkout?rep_id=2601860&licType=S&source=atm

2 Executive Summary

2.1 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size

2.1.1 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Revenue 2014-2025

2.1.2 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Production 2014-2025

2.2 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Growth Rate (CAGR) 2019-2025

2.3 Analysis of Competitive Landscape

2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

2.3.2 Key Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Manufacturers

2.3.2.1 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Manufacturing Base Distribution, Headquarters

2.3.2.2 Manufacturers Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Product Offered

2.3.2.3 Date of Manufacturers Enter into Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market

2.4 Key Trends for Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Markets & Products

3 Market Size by Manufacturers

3.1 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Production by Manufacturers

3.1.1 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Production by Manufacturers

3.1.2 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Production Market Share by Manufacturers

3.2 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Revenue by Manufacturers

3.2.1 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Revenue by Manufacturers (2019-2025)

3.2.2 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Revenue Share by Manufacturers (2019-2025)

3.3 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Price by Manufacturers

3.4 Mergers & Acquisitions, Expansion Plans

More Information.

Read the original here:
Research report covers the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Forecasts and Growth, 2019-2025 - Market Research...

Identification and Treatment of Tuberculosis in Pediatric Recipients o | IDR – Dove Medical Press

By adminJuly 30, 2020Stem Cell Treatment

Xiaodong Wang1,2 ,* Uet Yu2 ,* Xiaonan Li,3 Chunjing Wang,2 Qian Zhang,2 Chunlan Yang,2 Xiaoling Zhang,2 Yu Zhang,2 Ying Wang,2 Yuejie Zheng,3 Jikui Deng,4 Weiguo Yang,5 Guosheng Liu,1 Guofang Deng,6 Sixi Liu,2 Feiqiu Wen1,2

1Department of Pediatrics, First Affiliated Hospital of Jinan University, Guangzhou, Peoples Republic of China; 2Department of Hematology and Oncology, Shenzhen Childrens Hospital, Shenzhen, Guangdong, Peoples Republic of China; 3Department of Respiratory Diseases, Shenzhen Childrens Hospital, Shenzhen, Guangdong, Peoples Republic of China; 4Department of Infectious Diseases, Shenzhen Childrens Hospital, Shenzhen, Guangdong, Peoples Republic of China; 5Pediatric Intensive Care Unit, Shenzhen Childrens Hospital, Shenzhen, Guangdong, Peoples Republic of China; 6Guangdong Key Laboratory for Emerging Infectious Diseases & Shenzhen Key Laboratory of Infection and Immunity, Shenzhen Third Peoples Hospital, Shenzhen, Guangdong, Peoples Republic of China

*These authors contributed equally to this work

Correspondence: Sixi Liu; Feiqiu Wen Email tiger647@126.com; fwen62@163.com

Background: Tuberculosis is a rare but life-threatening complication in patients who received hematopoietic stem cell transplantation. Early identification and intervention are essential to prevent severe complications. Case Presentation: We report two pediatric patients who developed tuberculosis after receiving hematopoietic stem cell transplantation for thalassemia major among 330 recipients between January 2012 and August 2019. Patient A presented with pulmonary tuberculosis and patient B presented with lymph node tuberculosis mimicking post-transplantation lymphoproliferative disorder associated with EpsteinBarr virus reactivation. Patient Bs condition was deteriorated, and shortly after the initiation of anti-tuberculosis therapy, the patient was found to have disseminated pulmonary tuberculosis. Patient B was also found to have tuberculous granulomas, an uncommon manifestation of tuberculosis causing severe airway obstruction. Both patients developed critical respiratory failure and required mechanical ventilation; however, they recovered with almost full resolution of pulmonary lesions after multiple treatment adjustments. Conclusion: Tuberculosis must be carefully evaluated in all pediatric patients that receive hematopoietic stem cell transplantation, regardless of the identification of other pathogens. Prophylactic tuberculosis therapy should be considered for high-risk pediatric hematopoietic stem cell transplantation recipients from tuberculosis-endemic regions.

Keywords: tuberculosis, hematopoietic stem cell transplantation, thalassemia, pediatric

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.